Policy and priorities for national cancer control planning in low- and middle-income countries: Lessons from the Association of Southeast Asian Nations (ASEAN) Costs in Oncology prospective cohort study
ACTION Study Group,Nirmala Bhoo-Pathy,Cheng-Har Yip,Sanne A E Peters,Merel Kimman,Richard Sullivan,Stephen Ja,Mark Woodward,Chiu-Wan Ng,Phetsamone Arounlangsy,Soe Aung,Soledad L Balete,Bounthaphany Bounxouei,Dieu Bui,Jay Datukan,Agnes E Gorospe,Cheng Har Yip,Prasit Khopaibul,Thanut Khuayjarernpanishk,Thiravud Khuhaprema,Myo Khin,Tawin Klinwimol,Somkiet Lalitwongsa,Dhanoo Lawbundis,Conrado Lola,Gloria Cristal-Luna,Leo Marbella,Khoa Mai Trong,Soe Oo Maung,Shu Mon,Win Pa Pa Naing,Corazon A Ngelangel,Htun Lwin Nyein,Annielyn Beryl Ong-Cornel,Khin May Oo,Irisyl Orolfo-Real,Dung Pham Xuan,Seang Pharin,Pujianto,Oudayvone Rattanavong,Kouy Samnang,Somphob Sangkittipaiboon,Suleeporn Sangrajrang,Cherelina Santiago-Ferreras,Prih Sarnianto,San Shwe,Eav Sokha,Thanadej Sinthusake,Darunee Suanplua,Jitraporn Tanabodee,Hasbullah Thabrany,Kitisak Thepsuwan,Yin Yin Htun,Heng Viroath,Le Le Win,Swe Swe Win,Tin Moe Win,Ami Ashariati,Djumhana Atmakusuma,I Made Bakta,Loan Dang Thi Kim,Phung Dang Thi Ngoc,Tuan Diep Bao,Ario Djatmiko,Andi Fachruddin,Pik-Pin Goh,Johan Kurnianda,Helen Monaghan,Abdul Muthalib,Trang Ngo Thuy,Thao Nguyen Hoang,Nga Nguyen Thi Hoai,Sonar S Panigoro,Huy Pham Quang,Khanh Quach Thanh,Dradjat R Suardi,ShriDevi Subramaniam,Aru W Sudoyo,Khoa Tran Dang,Ha Tran Dinh,Catharina Suharti,Suyatno
DOI: https://doi.org/10.1016/j.ejca.2016.12.014
Abstract:Background: Evidence to guide policymakers in developing affordable and equitable cancer control plans are scarce in low- and middle-income countries (LMIC). Methods: The 2012-2014 ASEAN Costs in Oncology Study prospectively followed-up 9513 newly diagnosed cancer patients from eight LMIC in Southeast Asia for 12 months. Overall and country-specific incidence of financial catastrophe (out-of-pocket health costs ≥ 30% of annual household income), economic hardship (inability to make necessary household payments), poverty (living below national poverty line), and all-cause mortality were determined. Stepwise multinomial regression was used to estimate the extent to which health insurance, cancer stage and treatment explained these outcomes. Results: The one-year incidence of mortality (12% in Malaysia to 45% in Myanmar) and financial catastrophe (24% in Thailand to 68% in Vietnam) were high. Economic hardship was reported by a third of families, including inability to pay for medicines (45%), mortgages (18%) and utilities (12%), with 28% taking personal loans, and 20% selling assets (not mutually exclusive). Out of households that initially reported incomes above the national poverty levels, 4·9% were pushed into poverty at one year. The adverse economic outcomes in this study were mainly attributed to medical costs for inpatient/outpatient care, and purchase of drugs and medical supplies. In all the countries, cancer stage largely explained the risk of adverse outcomes. Stage-stratified analysis however showed that low-income patients remained vulnerable to adverse outcomes even when diagnosed with earlier cancer stages. Conclusion: The LMIC need to realign their focus on early detection of cancer and provision of affordable cancer care, while ensuring adequate financial risk protection, particularly for the poor.